ValiRx plc (AIM:VAL)
London · Delayed Price · Currency is GBP · Price in GBX 0.3165
-0.0085 (-2.62%)
Mar 5, 2026, 8:45 AM GMT
ValiRx Market Cap
ValiRx has a market cap or net worth of 2.41 million as of March 4, 2026. Its market cap has decreased by -0.79% in one year.
Market Cap
2.41M
Enterprise Value
1.46M
Revenue
49.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.32
Market Cap Chart
Since October 3, 2006, ValiRx's market cap has decreased from 12.83M to 2.41M, a decrease of -81.19%. That is a compound annual growth rate of -8.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 2.41M | -2.97% |
| Dec 31, 2025 | 2.49M | -14.24% |
| Dec 31, 2024 | 2.90M | -51.94% |
| Dec 29, 2023 | 6.04M | -33.71% |
| Dec 30, 2022 | 9.11M | -61.38% |
| Dec 31, 2021 | 23.58M | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oxford BioDynamics | 10.73M |
| Genflow Biosciences | 9.38M |
| Futura Medical | 7.25M |
| IXICO | 7.07M |
| CRISM Therapeutics | 6.85M |
| OptiBiotix Health | 6.46M |
| Cizzle Biotechnology Holdings | 5.95M |
| Theracryf | 4.51M |